thiophosphoric acid has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, M; Gorenstein, DG; Hu, A; Li, X; Mann, AP; Nieves-Alicea, R; Somasunderam, A; Sood, AK; Tanaka, T | 1 |
| Uma Devi, P | 1 |
| Bamberg, M; Cordes, N; Plasswilm, L; Rodemann, HP | 1 |
1 trial(s) available for thiophosphoric acid and Neoplasms
| Article | Year |
|---|---|
Normal tissue protection in cancer therapy--progress and prospects.
Topics: Humans; Neoplasms; Phosphates; Radiation-Protective Agents; Radiotherapy | 1998 |
2 other study(ies) available for thiophosphoric acid and Neoplasms
| Article | Year |
|---|---|
Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting.
Topics: Animals; Aptamers, Nucleotide; Base Sequence; Blood Circulation; Drug Screening Assays, Antitumor; E-Selectin; Endothelial Cells; HL-60 Cells; Humans; Kinetics; Ligands; Mice; Molecular Sequence Data; Neoplasms; Nucleic Acid Conformation; Phosphates; Protein Binding | 2010 |
Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Topics: Adjuvants, Immunologic; Alkaloids; Annexin A5; Apoptosis; Berberine Alkaloids; Blotting, Western; Cell Division; Cell Nucleus; Cell Survival; Chelidonium; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme Inhibitors; Fibroblasts; Flow Cytometry; Humans; Neoplasms; Phenanthridines; Phosphates; Radiation-Protective Agents; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |